Literature DB >> 29080990

Reirradiation of Skull Base Tumors With Advanced Highly Conformal Techniques.

Jennifer C Ho1, Jack Phan2.   

Abstract

PURPOSE OF REVIEW: Skull base reirradiation is challenging due to complex anatomy, enrichment of treatment-resistant clonogens, and increased risk of severe treatment complications. Without local therapy, early mortality is certain and tumor progression can result in debilitating symptoms. Modern radiotherapy advancements, such as image-guided radiation therapy (IGRT), intensity-modulated radiation therapy (IMRT), particle therapy, and stereotactic radiation therapy (SRT), are attractive for skull base reirradiation. RECENT
FINDINGS: Although limited by their retrospective nature and heterogeneous patient populations, several studies have demonstrated that reirradiation with these highly conformal techniques is feasible. Compared to IMRT or particle therapy reirradiation, SRT reirradiation appears promising with lower toxicity and increased convenience. Here, we provide thorough explanations for each technology and summarize the most relevant and recent studies, with particular attention to efficacy and toxicity. Skull base reirradiation using these extremely conformal therapy techniques requires meticulous treatment planning and should be delivered by experienced teams.

Entities:  

Keywords:  Head and neck cancer; Proton therapy; Radiosurgery; Reirradiation; Skull base; Stereotactic

Mesh:

Year:  2017        PMID: 29080990     DOI: 10.1007/s11912-017-0639-9

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  50 in total

1.  Stereotactic body radiation therapy for inoperable early stage lung cancer.

Authors:  Robert Timmerman; Rebecca Paulus; James Galvin; Jeffrey Michalski; William Straube; Jeffrey Bradley; Achilles Fakiris; Andrea Bezjak; Gregory Videtic; David Johnstone; Jack Fowler; Elizabeth Gore; Hak Choy
Journal:  JAMA       Date:  2010-03-17       Impact factor: 56.272

Review 2.  The clinical application of intensity-modulated radiation therapy.

Authors:  Randall K Ten Haken; Theodore S Lawrence
Journal:  Semin Radiat Oncol       Date:  2006-10       Impact factor: 5.934

3.  Re-irradiation of adenoid cystic carcinoma: analysis and evaluation of outcome in 52 consecutive patients treated with raster-scanned carbon ion therapy.

Authors:  Alexandra D Jensen; Melanie Poulakis; Anna V Nikoghosyan; Naved Chaudhri; Matthias Uhl; Marc W Münter; Klaus K Herfarth; Jürgen Debus
Journal:  Radiother Oncol       Date:  2015-01-29       Impact factor: 6.280

4.  Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.

Authors:  A A Forastiere; B Metch; D E Schuller; J F Ensley; L F Hutchins; P Triozzi; J A Kish; S McClure; E VonFeldt; S K Williamson
Journal:  J Clin Oncol       Date:  1992-08       Impact factor: 44.544

5.  Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Authors:  Joe Y Chang; Suresh Senan; Marinus A Paul; Reza J Mehran; Alexander V Louie; Peter Balter; Harry J M Groen; Stephen E McRae; Joachim Widder; Lei Feng; Ben E E M van den Borne; Mark F Munsell; Coen Hurkmans; Donald A Berry; Erik van Werkhoven; John J Kresl; Anne-Marie Dingemans; Omar Dawood; Cornelis J A Haasbeek; Larry S Carpenter; Katrien De Jaeger; Ritsuko Komaki; Ben J Slotman; Egbert F Smit; Jack A Roth
Journal:  Lancet Oncol       Date:  2015-05-13       Impact factor: 41.316

6.  A nomogram to predict loco-regional control after re-irradiation for head and neck cancer.

Authors:  Nadeem Riaz; Julian C Hong; Eric J Sherman; Luc Morris; Matthew Fury; Ian Ganly; Tony J C Wang; Weji Shi; Suzanne L Wolden; Andrew Jackson; Richard J Wong; Zhigang Zhang; Shyam D Rao; Nancy Y Lee
Journal:  Radiother Oncol       Date:  2014-06-30       Impact factor: 6.280

7.  A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck.

Authors:  C Jacobs; G Lyman; E Velez-García; K S Sridhar; W Knight; H Hochster; L T Goodnough; J E Mortimer; L H Einhorn; L Schacter
Journal:  J Clin Oncol       Date:  1992-02       Impact factor: 44.544

8.  Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911.

Authors:  Corey J Langer; Jonathan Harris; Eric M Horwitz; Nicos Nicolaou; Merrill Kies; Walter Curran; Stuart Wong; Kian Ang
Journal:  J Clin Oncol       Date:  2007-10-20       Impact factor: 44.544

9.  Long-term follow-up of stereotactic radiosurgery for head and neck malignancies.

Authors:  Dawn Owen; Fawaad Iqbal; Bruce E Pollock; Michael J Link; Kathy Stien; Yolanda I Garces; Paul D Brown; Robert L Foote
Journal:  Head Neck       Date:  2014-08-01       Impact factor: 3.147

10.  Improved setup and positioning accuracy using a three-point customized cushion/mask/bite-block immobilization system for stereotactic reirradiation of head and neck cancer.

Authors:  He Wang; Congjun Wang; Samuel Tung; Andrew Wilson Dimmitt; Pei Fong Wong; Mark A Edson; Adam S Garden; David I Rosenthal; Clifton D Fuller; Gary B Gunn; Vinita Takiar; Xin A Wang; Dershan Luo; James N Yang; Jennifer Wong; Jack Phan
Journal:  J Appl Clin Med Phys       Date:  2016-05-08       Impact factor: 2.102

View more
  1 in total

1.  Salvage Therapy for Local Progression following Definitive Therapy for Skull Base Chordomas: Is There a Role of Stereotactic Radiosurgery?

Authors:  Linton T Evans; Franco DeMonte; David R Grosshans; Amol J Ghia; Ahmed Habib; Shaan M Raza
Journal:  J Neurol Surg B Skull Base       Date:  2019-02-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.